Around 75 per cent of ovarian tumors arise from the fallopian tube. There are currently no options for detecting this condition early or preventing it. With the help of an innovative, "three-way" ...
Los Angeles, Calif. - January 15, 2009 - Avalon Laboratories, LLC (Avalon) today announced it has received 510(k) clearances from the U.S. Food and Drug Administration (FDA) and CE Mark acceptance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results